(비상장) AI신약개발벤처사 글로벌 BD임원 구인(석박사)
본문
Senior Director BD Professional What’ll do you Qualifications As a senior leader on Galux's Business Development team, you will define and own Galux's external partnering strategy, serve as the company's primary representative to global pharma and investor audiences, and play a direct role in shaping pipeline and portfolio decisions. This is not an execution-heavy role supported by a large team; you will operate as a strategic leader who is also hands-on in a lean startup environment. Specifically, you will: • Define Galux's partnering and out-licensing strategy, including identifying which assets and platform capabilities to bring to market, when to initiate partnering processes, which partner archetypes to prioritize, and when to walk away from a deal. • Serve as Galux's primary external face in partnering contexts, leading executive-level discussions with global pharma and biotech BD and C-suite counterparts, investor audiences, and key opinion leaders at international conferences. • Lead high-value negotiations as primary deal lead, making real-time judgment calls on deal structure, term tradeoffs, and competitive dynamics across the table from senior pharma counterparts. • Advise the executive team on portfolio strategy, including go/no-go decisions on partnerships, timing of out-licensing relative to value-inflection milestones, and resource-allocation tradeoffs between internal development and external collaboration. • Create and sustain competitive tension among potential partners by managing parallel partnering processes and controlling information flow and timing strategically. • Independently assess and interpret Galux's R&D outputs and pipeline data to form your own view on asset value, partnering readiness, and how to position scientific narratives for different audiences. • Steward active alliances at a strategic level, ensuring partnerships deliver on milestones, escalating and resolving issues at the executive level, and protecting Galux's long-term interests across multi-year collaborations. • Build and institutionalize Galux's BD function by establishing processes, standards, and tools that scale as the company and team grow, and by mentoring and developing junior BD team members. • Bachelor's degree in related life sciences disciplines. • 10+ years of experience in biopharma business development, licensing, or M&A, including 5+ years as primary deal lead responsible for structuring, negotiating, and closing transactions. • Demonstrated track record of closed deals with measurable commercial outcomes, not just involvement but ownership of transactions from origination through execution
• Strong scientific fluency with the ability to independently interpret preclinical and clinical data, critically evaluate asset value, and engage credibly with senior R&D counterparts at partner organizations. • Fluent in English (written and spoken), with the ability to lead negotiations, deliver executive-level presentations, and represent Galux with authority in high-stakes partnering and investor settings. • Established and active network of senior BD, licensing, and R&D contacts across global pharma and biotech, with the ability to leverage existing relationships to accelerate deal origination and open doors that would otherwise be inaccessible to an early-stage company.
Preferred Qualifications • Gravitas and credibility to represent Galux as a peer in discussions with SVP and C-suite-level counterparts at global pharma companies. • Alliance governance instincts, knowing how to protect Galux's position in long-term partnerships, escalate issues before they become problems, and ensure collaborations deliver sustained value. • Comfortable establishing BD processes, infrastructure, and team culture from a relatively early stage, rather than inheriting a mature function. • MS or PhD in a relevant life sciences discipline, or MD. • Familiarity with AI-driven drug discovery or computational biology platforms. • Experience in out-licensing or platform technology partnerships specifically, not only traditional single-asset deals. • Direct involvement in portfolio governance or pipeline prioritization decisions at a previous organization. • Track record of building or scaling a BD team, including hiring, developing, and retaining talent.
• Strong scientific fluency with the ability to independently interpret preclinical and clinical data, critically evaluate asset value, and engage credibly with senior R&D counterparts at partner organizations. • Fluent in English (written and spoken), with the ability to lead negotiations, deliver executive-level presentations, and represent Galux with authority in high-stakes partnering and investor settings. • Established and active network of senior BD, licensing, and R&D contacts across global pharma and biotech, with the ability to leverage existing relationships to accelerate deal origination and open doors that would otherwise be inaccessible to an early-stage company.
Preferred Qualifications • Gravitas and credibility to represent Galux as a peer in discussions with SVP and C-suite-level counterparts at global pharma companies. • Alliance governance instincts, knowing how to protect Galux's position in long-term partnerships, escalate issues before they become problems, and ensure collaborations deliver sustained value. • Comfortable establishing BD processes, infrastructure, and team culture from a relatively early stage, rather than inheriting a mature function. • MS or PhD in a relevant life sciences discipline, or MD. • Familiarity with AI-driven drug discovery or computational biology platforms. • Experience in out-licensing or platform technology partnerships specifically, not only traditional single-asset deals. • Direct involvement in portfolio governance or pipeline prioritization decisions at a previous organization. • Track record of building or scaling a BD team, including hiring, developing, and retaining talent.